Literature DB >> 22848233

The role of components of the chromatin modification machinery in carcinogenesis of clear cell carcinoma of the ovary (Review).

Hiroshi Shigetomi1, Akira Oonogi, Taihei Tsunemi, Yasuhito Tanase, Yoshihiko Yamada, Hirotaka Kajihara, Yoriko Yoshizawa, Naoto Furukawa, Shoji Haruta, Shozo Yoshida, Toshiyuki Sado, Hidekazu Oi, Hiroshi Kobayashi.   

Abstract

Recent data have provided information regarding the profiles of clear cell carcinoma of the ovary (CCC) with adenine-thymine rich interactive domain 1A (ARID1A) mutations. The purpose of this review was to summarize current knowledge regarding the molecular mechanisms involved in CCC tumorigenesis and to describe the central role played by the aberrant chromatin remodeling. The present article reviews the English-language literature for biochemical studies on the ARID1A mutation and chromatin remodeling in CCC. ARID1A is responsible for directing the SWI/SNF complex to target promoters and regulates the transcription of certain genes by altering the chromatin structure around those genes. The mutation spectrum of ARID1A was enriched for C to T transitions. CCC and clear cell renal cell carcinoma (ccRCC) resemble each other pathogenetically. Dysfunction of the ARID1A protein, which occurs with VHL mutations in ccRCC, is responsible for loss of the assembly of the ARID1A-mediated histone H2B complex. Therefore, ARID1A acts as a chromatin remodeling modifier, which stimulates cell signaling that can lead to cell cycle arrest and cell death in the event of DNA damage. The dysfunction of ARID1A may result in susceptibility to CCC carcinogenesis through a defect in the repair or replication of damaged DNA.

Entities:  

Year:  2011        PMID: 22848233      PMCID: PMC3406481          DOI: 10.3892/ol.2011.316

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  54 in total

Review 1.  ARID proteins: a diverse family of DNA binding proteins implicated in the control of cell growth, differentiation, and development.

Authors:  Deborah Wilsker; Antonia Patsialou; Peter B Dallas; Elizabeth Moran
Journal:  Cell Growth Differ       Date:  2002-03

2.  Proteasomal ATPases link ubiquitylation of histone H2B to methylation of histone H3.

Authors:  Elena Ezhkova; William P Tansey
Journal:  Mol Cell       Date:  2004-02-13       Impact factor: 17.970

3.  Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.

Authors: 
Journal:  Oncologist       Date:  1996

4.  Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci.

Authors:  X Jiang; A Hitchcock; E J Bryan; R H Watson; P Englefield; E J Thomas; I G Campbell
Journal:  Cancer Res       Date:  1996-08-01       Impact factor: 12.701

5.  Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan.

Authors:  H Kobayashi; K Sumimoto; N Moniwa; M Imai; K Takakura; T Kuromaki; E Morioka; K Arisawa; T Terao
Journal:  Int J Gynecol Cancer       Date:  2007 Jan-Feb       Impact factor: 3.437

6.  Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma.

Authors:  Siân Jones; Tian-Li Wang; Ie-Ming Shih; Tsui-Lien Mao; Kentaro Nakayama; Richard Roden; Ruth Glas; Dennis Slamon; Luis A Diaz; Bert Vogelstein; Kenneth W Kinzler; Victor E Velculescu; Nickolas Papadopoulos
Journal:  Science       Date:  2010-09-08       Impact factor: 47.728

7.  The histone demethylase UTX enables RB-dependent cell fate control.

Authors:  Jordon K Wang; Miao-Chih Tsai; Gino Poulin; Adam S Adler; Shuzhen Chen; Helen Liu; Yang Shi; Howard Y Chang
Journal:  Genes Dev       Date:  2010-02-01       Impact factor: 11.361

Review 8.  The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinoma.

Authors:  Roxana I Sufan; Michael A S Jewett; Michael Ohh
Journal:  Am J Physiol Renal Physiol       Date:  2004-07

Review 9.  Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications.

Authors:  Robert J Kurman; Ie-Ming Shih
Journal:  Int J Gynecol Pathol       Date:  2008-04       Impact factor: 2.762

Review 10.  New insights into prion biology from the novel [SWI+] system.

Authors:  Emily Crow; Zhiqiang Du; Liming Li
Journal:  Prion       Date:  2008 Oct-Dec       Impact factor: 3.931

View more
  9 in total

1.  ARID1A knockdown triggers epithelial-mesenchymal transition and carcinogenesis features of renal cells: role in renal cell carcinoma.

Authors:  Keerakarn Somsuan; Paleerath Peerapen; Wanida Boonmark; Sirikanya Plumworasawat; Ratirath Samol; Natthiya Sakulsak; Visith Thongboonkerd
Journal:  FASEB J       Date:  2019-08-21       Impact factor: 5.191

2.  RRM2 gene expression depends on BAF180 subunit of SWISNF chromatin remodeling complex and correlates with abundance of tumor infiltrating lymphocytes in ccRCC.

Authors:  Joanna Szarkowska; Pawel Cwiek; Michal Szymanski; Natalia Rusetska; Iga Jancewicz; Malgorzata Stachowiak; Monika Swiatek; Maciej Luba; Ryszard Konopinski; Szymon Kubala; Renata Zub; Jakub Kucharz; Pawel Wiechno; Janusz A Siedlecki; Sergiusz Markowicz; Elzbieta Sarnowska; Tomasz J Sarnowski
Journal:  Am J Cancer Res       Date:  2021-12-15       Impact factor: 6.166

3.  Microduplication of the ARID1A gene causes intellectual disability with recognizable syndromic features.

Authors:  Marie Bidart; Michèle El Atifi; Sarra Miladi; John Rendu; Véronique Satre; Pierre F Ray; Caroline Bosson; Françoise Devillard; Daphné Lehalle; Valérie Malan; Jeanne Amiel; Maria Antonietta Mencarelli; Margherita Baldassarri; Alessandra Renieri; Jill Clayton-Smith; Gaëlle Vieville; Julien Thevenon; Florence Amblard; François Berger; Pierre-Simon Jouk; Charles Coutton
Journal:  Genet Med       Date:  2016-12-01       Impact factor: 8.822

Review 4.  Clinical crosstalk between microRNAs and gastric cancer (Review).

Authors:  Jing Ouyang; Zhizhong Xie; Xiaoyong Lei; Guotao Tang; Runliang Gan; Xiaoyan Yang
Journal:  Int J Oncol       Date:  2021-03-02       Impact factor: 5.650

5.  Chromatin Remodeler Smarca5 Is Required for Cancer-Related Processes of Primary Cell Fitness and Immortalization.

Authors:  Shefali Thakur; Vincent Cahais; Tereza Turkova; Tomas Zikmund; Claire Renard; Tomáš Stopka; Michael Korenjak; Jiri Zavadil
Journal:  Cells       Date:  2022-02-25       Impact factor: 6.600

Review 6.  Impact of SARS-CoV-2 on Host Factors Involved in Mental Disorders.

Authors:  Raina Rhoades; Sarah Solomon; Christina Johnson; Shaolei Teng
Journal:  Front Microbiol       Date:  2022-04-04       Impact factor: 6.064

7.  Laparoscopic management of pedicle torsion of adnexal cysts.

Authors:  Yuxia Wang; Yuanyuan Xie; Xiaoqing Wu; Lu Li; Yifei Ma; Xiaoyuan Wang
Journal:  Oncol Lett       Date:  2013-03-05       Impact factor: 2.967

Review 8.  New strategies in ovarian cancer treatment.

Authors:  Jung-Min Lee; Lori Minasian; Elise C Kohn
Journal:  Cancer       Date:  2019-12-15       Impact factor: 6.921

9.  Nuclear-encoded mitochondrial MTO1 and MRPL41 are regulated in an opposite epigenetic mode based on estrogen receptor status in breast cancer.

Authors:  Tae Woo Kim; Byungtak Kim; Ju Hee Kim; Seongeun Kang; Sung-Bin Park; Gookjoo Jeong; Han-Sung Kang; Sun Jung Kim
Journal:  BMC Cancer       Date:  2013-10-27       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.